HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain-Reference-Cited by-同舟云学术

HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain

Published:2012-12 Issue:12 Volume:1818 Page:2950-2957
ISSN:0005-2736
Container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes

Author:

Lu Lu,Tong Pei,Yu Xiaowen,Pan Chungen,Zou Peng,Chen Ying-Hua,Jiang Shibo

Funder

Natural Science Foundation of China

National 973 Program of China

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry,Biophysics

Reference55 articles.

1. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens;Wyatt;Science,1998

2. Mode of insertion into a lipid membrane of the N-terminal HIV gp41 peptide segment;Brasseur;AIDS Res. Hum. Retroviruses,1988

3. Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites;He;J. Virol.,2003

4. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion — structure-function study;Kliger;J. Biol. Chem.,1997

5. Atomic structure of a thermostable subdomain of HIV-1 gp41;Tan;Proc. Natl. Acad. Sci. U. S. A.,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients;AIDS Research and Human Retroviruses;2024-08-01

2. ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41;Current Research in Microbial Sciences;2024

3. Analysis of HIV latent infection model with multiple infection stages and different drug classes;Journal of Biological Dynamics;2022-10-20

4. Heptad stereotypy, S/Q layering, and remote origin of the SARS-CoV-2 fusion core;Virus Evolution;2021-12-15

5. Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection;Molecules;2021-03-31